SAM
EMN icon

Scopus Asset Management’s Eastman Chemical EMN Stock Holding History

Scopus Asset Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200,000
Closed -$20M – 243
2024
Q1 		$20M Buy
+200,000
New +$17.6M 0.41% 83

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Scopus Asset Management's EMN Position: Q2 2021 in Review

Scopus Asset Management sold out of Eastman Chemical (EMN) in Q2 2021, closing a stake of 110,000 shares — an estimated $12.1M sold.

Scopus Asset Management first reported a position in EMN in Q3 2013 and held it in 20 quarters. The position peaked at $26.3M in Q2 2014. 723 funds tracked by Wall St. Rank hold EMN as of Q2 2021.

  • Scopus Asset Management reported no remaining Eastman Chemical position as of Q2 2021 after selling out during the quarter.
  • Scopus Asset Management sold 110,000 Eastman Chemical shares in Q2 2021, an estimated $12.1M.
  • Scopus Asset Management first reported a position in Eastman Chemical in Q3 2013 and held it in 20 quarters.
  • Scopus Asset Management's Eastman Chemical position peaked at $26.3M in Q2 2014.
  • 723 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2021.

Based on Scopus Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.